The suppression of miR-322–5p lifts its inhibitory effect on IGF-1, resulting in increased IGF-1 expression, which further promotes the pathological processes associated with PAH (Connolly et al., 2018). Here, IGF1 is linked to pulmonary arterial hypertension.